Groups like Patients for Affordable Drugs Now (P4AD) and Families USA are pressing senators to include patent reforms in an upcoming drug-pricing package that Majority Leader Chuck Schumer has suggested will include measures to reform how pharmacy benefit managers conduct business with federal and private health plans and extend implementation of monthly out-of-pocket cost-sharing caps for insulin to the commercial market. P4AD, which launched a six-figure ad campaign last Thursday (Sept. 7) pushing senators to move on Schumer’s highly anticipated...